Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interferons and Resistance Mechanisms in Tumors and Pathogen-Driven Diseases-Focus on the Major Histocompatibility Complex (MHC) Antigen Processing Pathway. | Int J Mol Sci | 2023 | 37047709 | PubTator, text mining | PubMed |
| Investigating combination benefit of PD1 and LAG3 co-blockade using an engineered cellular bioassay. | Int Immunopharmacol | 2023 | 37044037 | PubTator, text mining | PubMed |
| Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions. | Front Oncol | 2023 | 37035197 | PubTator, text mining | PubMed |
| Identification of berberine as a potential therapeutic strategy for kidney clear cell carcinoma and COVID-19 based on analysis of large-scale datasets. | Front Immunol | 2023 | 37033923 | PubTator, text mining | PubMed |
| Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemia. | Cancer Cell Int | 2023 | 37024911 | PubTator, text mining | PubMed |
| Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia. | Front Oncol | 2023 | 37020867 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas. | Cell Chem Biol | 2023 | 37015223 | PubTator, text mining | PubMed |
Risk Indicators of Sarcoidosis Evolution-Unified Protocol (RISE-UP): protocol for a multi-centre, longitudinal, observational study to identify clinical features that are predictive of sarcoidosis progression. | BMJ Open | 2023 | 37012011 | PubTator, text mining | PubMed |
| The Multifaceted Immunology of Cytokine Storm Syndrome. | J Immunol | 2023 | 37011407 | PubTator, text mining | PubMed |
| Isolated bone marrow gamma-delta T-Cell lymphoma: Another challenge to the WHO lymphoid neoplasm classification. | Leuk Res Rep | 2023 | 37006952 | PubTator, text mining | PubMed |
| Mapping the SLP76 interactome in T cells lacking each of the GRB2-family adaptors reveals molecular plasticity of the TCR signaling pathway. | Front Immunol | 2023 | 37006259 | PubTator, text mining | PubMed |
| Tumor microenvironment signaling and therapeutics in cancer progression. | Cancer Commun (Lond) | 2023 | 37005490 | PubTator, text mining | PubMed |
| PROTAC'ing oncoproteins: targeted protein degradation for cancer therapy. | Mol Cancer | 2023 | 36991452 | PubTator, text mining | PubMed |
| Targeted Two-Step Delivery of Oncotheranostic Nano-PLGA for HER2-Positive Tumor Imaging and Therapy In Vivo: Improved Effectiveness Compared to One-Step Strategy. | Pharmaceutics | 2023 | 36986694 | PubTator, text mining | PubMed |
| Structural Complementarity of Bruton's Tyrosine Kinase and Its Inhibitors for Implication in B-Cell Malignancies and Autoimmune Diseases. | Pharmaceuticals (Basel) | 2023 | 36986499 | PubTator, text mining | PubMed |
| The Development of New Agents for Post-Hematopoietic Stem Cell Transplantation Non-Infectious Complications in Children. | J Clin Med | 2023 | 36983151 | PubTator, text mining | PubMed |
| Fer and FerT: A New Regulatory Link between Sperm and Cancer Cells. | Int J Mol Sci | 2023 | 36982326 | PubTator, text mining | PubMed |
| The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies. | Cancers (Basel) | 2023 | 36980798 | PubTator, text mining | PubMed |
| CXCL1 and CXCL6 Are Potential Predictors for HCC Response to TACE. | Curr Oncol | 2023 | 36975480 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=18